Dr. Yongquan Luo received his Ph.D. from SUNY Health Science Center at Brooklyn specializing in chemosensory system. After that, he extended his research into fields of age-related neurodegenerative diseases and stem cells. Now, he is pursuing studies of mutation of gene WHAMM on pathogenesis in Axial spondyloarthritis using patient derived hiPSCs and CRISPR/Cas9 technologies.